Vitamin D and multiple sclerosis have been linked for decades, but how strong is the evidence – and what does it mean for clinical practice?
In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Eric Thouvenot fromUniversity Hospital of Nimesand Dr. Deborah Mason fromChristchurch Hospitalabout the evolving science behind vitamin D and MS.
Together, they explore:
Why vitamin D deficiency is associated with increased MS risk
The influence of latitude, sunlight exposure and genetics
How vitamin D affects immune regulation and inflammation
Findings from recent vitamin D supplementation trials
As researchers continue to investigate vitamin D's role in MS, this episode provides a balanced look at what we know, what remains uncertain, and what it means for patient care.
____________________________
This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.
Podden och tillhörande omslagsbild på den här sidan tillhör
The European Committee for Treatment and Research in Multiple Sclerosis. Innehållet i podden är skapat av The European Committee for Treatment and Research in Multiple Sclerosis och inte av,
eller tillsammans med, Poddtoppen.